One of the most reliable patterns in human health is that women, on average, live longer than men. It is often read as good news for women, and in many ways it is. But a growing body of research shows that those extra years are not all healthy ones. Women tend to spend more of their lives living with illness and disability than men do.
Part of that gap reflects biology and the conditions that become more common with age. But researchers are also pointing to blind spots in how medicine has studied, diagnosed and treated women, from how heart attacks are recognized to how drug doses are set.
Longer lives, more years unwell
In December 2024, Armin Garmany and Andre Terzic of the Mayo Clinic published an analysis in JAMA Network Open comparing lifespan with healthspan, the number of years lived in good health, across 183 World Health Organization member states. Using WHO data covering two decades, they calculated the gap between the two for each country.
Globally, the gap reached 9.6 years in 2019, up 13 percent since 2000. People were living longer, but healthy years were not keeping pace. The difference was larger for women. On average, women’s gap between lifespan and healthspan was 2.4 years wider than men’s.
The researchers linked this mainly to a higher burden of noncommunicable diseases in women. Neurological, musculoskeletal, urinary and genital tract disorders were among the conditions contributing to extra years of poor health among women. Terzic noted that because women live longer on average, they are also exposed to more years of risk for chronic disease and disability.
A separate report released in January 2024 by the World Economic Forum and the McKinsey Health Institute reached a similar conclusion. It estimated that women spend 25 percent more of their lives in poor health than men, and that much of that time falls during working age rather than only at the end of life.
Heart attacks that are missed
Heart disease is often thought of as a man’s problem, and that perception appears to affect how quickly women are diagnosed. In 2016, researchers led by Chris Gale at the University of Leeds published a study in the European Heart Journal: Acute Cardiovascular Care drawing on the national heart attack register for England and Wales.
The team looked at 564,412 patients treated for a heart attack over nine years to March 2013, and compared each patient’s first diagnosis in hospital with the final one. Almost a third of patients overall had an initial diagnosis that differed from their final diagnosis.
Women fared worse. Among patients whose final diagnosis was the more severe type of heart attack, known as STEMI, women had a 59 percent greater chance than men of being misdiagnosed at first. For the more common NSTEMI type, the figure was 41 percent. Together, the British Heart Foundation, which part-funded the study, put the overall difference at around 50 percent.
The consequences can be serious. Patients who were initially misdiagnosed had about a 70 percent higher risk of death within 30 days than those who were diagnosed correctly from the start, a pattern seen in both women and men.
Gale has pointed to the stereotype of a heart attack patient as a middle-aged, overweight man who smokes. Part of the problem is also technical. A blood test commonly used to diagnose heart attacks measures a protein called troponin, and women can have lower troponin levels even during a heart attack. Using sex-specific thresholds for the test has been shown to help more women receive a correct diagnosis.
Drug doses based on men
Another blind spot lies in medicines. For decades, many drugs were tested mostly in men, and women today usually receive the same doses. In 2020, Irving Zucker of the University of California, Berkeley and Brian Prendergast of the University of Chicago examined published data on how the body processes drugs, a field known as pharmacokinetics, and published their findings in Biology of Sex Differences.
They identified 86 drugs with clear evidence of sex differences. For 76 of them, women had higher concentrations of the drug in their blood and took longer to clear it. Where side effects could be compared, these differences predicted which sex experienced more adverse reactions in 88 percent of cases. Drugs that reached higher levels in women were associated with more side effects in women in 96 percent of cases.
Importantly, the difference was not explained simply by women weighing less on average. The authors noted that women experience adverse drug reactions nearly twice as often as men and suggested that women may routinely be overmedicated. They called for dosing evidence to be broken down by sex and for clearer labeling of drugs known to act differently in women.
What helps
None of this means women’s health outcomes are fixed. Researchers emphasize that these gaps are partly the product of gaps in knowledge, and knowledge can change. Since 1993, the US National Institutes of Health has required women to be included in federally funded clinical trials, and awareness of sex differences in medicine has grown.
For individuals, the research points to a few practical steps:
- Know that heart attack symptoms in women are not always the classic crushing chest pain. Discomfort in the jaw, neck, back or stomach, breathlessness, nausea and unusual fatigue can all be warning signs. Call emergency services rather than waiting.
- If a diagnosis does not seem to fit, it is reasonable to ask whether a heart problem has been ruled out.
- When starting a new medicine, ask whether the usual dose is appropriate, and report side effects promptly rather than putting up with them.
- Pay attention to conditions that often affect women more, such as musculoskeletal problems, and raise them early rather than treating them as an inevitable part of ageing.
The bigger picture
The finding that women outlive men is real. But longer life is not the same as more healthy life. The evidence suggests that some of the extra years women spend unwell reflect conditions that have been under-studied, under-diagnosed or treated with tools designed around men.
The WEF and McKinsey report estimated that closing the women’s health gap could reduce the time women spend in poor health by almost two-thirds. That figure is a projection rather than a measured outcome, but it underlines the point many researchers now make: a significant share of the health gap between women and men may be within reach of better research and care.
Representative image. Photo: Antoni Shkraba / Pexels.
Spot an error in this article? Email [email protected]


